Clinical Trial Update: Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France

View source ↗

Summary

Real-world study update evaluating ribociclib use and outcomes in women with HR+/HER2- advanced or metastatic breast cancer in France; the trial is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• KISQALI (ribociclib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Cancer | Status: ACTIVE_NOT_RECRUITING